Clariene SE [CLARI] vs Orpea [ORP] Detailed Stock Comparison
Clariene SE
Euronext
Loading...
Orpea
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Clariene SE wins in 9 metrics, Orpea wins in 8 metrics, with 0 ties. Clariene SE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Clariene SE | Orpea | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 9.76 | 0.10 | Orpea |
| Price-to-Book Ratio | 0.43 | 0.85 | Clariene SE |
| Debt-to-Equity Ratio | 209.58 | 485.11 | Clariene SE |
| PEG Ratio | 54.65 | 41.04 | Orpea |
| EV/EBITDA | 7.15 | 25.86 | Clariene SE |
| Profit Margin (TTM) | -1.16% | 26.07% | Orpea |
| Operating Margin (TTM) | 3.80% | -0.11% | Clariene SE |
| EBITDA Margin (TTM) | 3.80% | N/A | N/A |
| Return on Equity | -1.54% | 704.66% | Orpea |
| Return on Assets (TTM) | 1.34% | -0.07% | Clariene SE |
| Free Cash Flow (TTM) | $600.10M | $225.10M | Clariene SE |
| 1-Year Return | 130.85% | 32.82% | Clariene SE |
| Price-to-Sales Ratio (TTM) | 0.29 | 0.38 | Clariene SE |
| Enterprise Value | $9.34B | $10.10B | Orpea |
| EV/Revenue Ratio | 1.76 | 1.94 | Clariene SE |
| Revenue per Share (TTM) | $15 | $501 | Orpea |
| Earnings per Share (Diluted) | $-0.03 | $129.13 | Orpea |
| Beta (Stock Volatility) | 0.88 | 0.72 | Orpea |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Clariene SE vs Orpea Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Clariene SE | -3.00% | -2.03% | -17.02% | 15.12% | 65.65% | 101.86% |
| Orpea | 0.23% | -5.46% | 13.15% | 18.74% | 61.77% | 113.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Clariene SE | 130.85% | -43.27% | -43.27% | -43.27% | -43.27% | -43.27% |
| Orpea | 32.82% | -99.21% | -99.81% | -99.71% | -47.20% | -47.20% |
Performance & Financial Health Analysis: Clariene SE vs Orpea
| Metric | CLARI | ORP |
|---|---|---|
| Market Information | ||
| Market Cap | €1.56B | €1.96B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 987,999 | 322,075 |
| 90 Day Avg. Volume | 640,374 | 340,906 |
| Last Close | €4.34 | €12.99 |
| 52 Week Range | €1.49 - €5.51 | €4.44 - €14.22 |
| % from 52W High | -21.24% | -8.65% |
| All-Time High | €7.80 (Jun 12, 2023) | €8,238.46 (Feb 17, 2020) |
| % from All-Time High | -44.36% | -99.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.11% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.26% |
| Operating Margin (TTM) | 0.04% | 0.00% |
| Return on Equity (TTM) | -0.02% | 7.05% |
| Debt to Equity (MRQ) | 209.58 | 485.11 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €10.08 | €14.53 |
| Cash per Share (MRQ) | €2.13 | €5.34 |
| Operating Cash Flow (TTM) | €882.73M | €366.14M |
| Levered Free Cash Flow (TTM) | €1.38B | €776.41M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | €0.00 | €0.00 |
Valuation & Enterprise Metrics Analysis: Clariene SE vs Orpea
| Metric | CLARI | ORP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 9.76 | 0.10 |
| Forward P/E | 54.65 | 41.04 |
| PEG Ratio | 54.65 | 41.04 |
| Price to Sales (TTM) | 0.29 | 0.38 |
| Price to Book (MRQ) | 0.43 | 0.85 |
| Market Capitalization | ||
| Market Capitalization | €1.56B | €1.96B |
| Enterprise Value | €9.34B | €10.10B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.76 | 1.94 |
| Enterprise to EBITDA | 7.15 | 25.86 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.72 |
| Book Value per Share (MRQ) | €10.08 | €14.53 |
Financial Statements Comparison: Clariene SE vs Orpea
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLARI | ORP |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLARI | ORP |
|---|---|---|
| Cash & Equivalents | €518.07M | €644.95M |
| Total Current Assets | €1.64B | €2.37B |
| Total Current Liabilities | €2.91B | €3.12B |
| Long-Term Debt | €6.59B | €7.86B |
| Total Shareholders Equity | €4.02B | €1.89B |
| Retained Earnings | N/A | €1.35B |
| Property, Plant & Equipment | €5.45B | €11.30B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLARI | ORP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CLARI | ORP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 987,999 | 322,075 |
| Average Daily Volume (90 Day) | 640,374 | 340,906 |
| Shares Outstanding | 355.70M | 159.12M |
| Float Shares | 194.45M | 85.22M |
| % Held by Insiders | 0.31% | 0.05% |
| % Held by Institutions | 0.43% | 0.45% |
Dividend Analysis & Yield Comparison: Clariene SE vs Orpea
| Metric | CLARI | ORP |
|---|---|---|
| Last 12-Month Dividend | €0.00 | €0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | €0.08 | €0.00 |
| 3-Year Avg Dividend Yield | 3.80% | N/A |
| 3-Year Total Dividends | €0.25 | €0.00 |
| Ex-Dividend Date | Jun 21, 2023 | N/A |